Study: No Thimerosal Link to Autism
Exposure to Thimerosal in the Womb Does Not Raise Risk of Autism
WebMD News Archive
May 16, 2007 -- New research adds to the evidence showing no causal link
between autism and the mercury-containing preservative thimerosal.
Researchers compared records of children exposed to thimerosal while in the
womb and those not exposed and found no difference in autism rates.
The study is one of the first to look at exposure to mercury-containing
vaccines during the last months of pregnancy.
Rh Protein and Thimerosal
The Rh protein shot is routinely given to pregnant women who are
Rh-negative. These women lack the Rh protein on the surface of their red blood
cells. The injection prevents Rh disease, which can cause the fetus to be
stillborn or lead to fatal illnesses in the newborn.
It has been suggested that children born to mothers who are given injections
of Rh protein during pregnancy may be at increased risk for autism because
thimerosal was used in the Rh protein injection until 2001.
"We hypothesized that if thimerosal were associated with the development
of autism, we would find a higher proportion of Rh negative mothers of children
with autism born before 2002," University of Missouri researchers Judith H.
Miles, MD, PhD, and T. Nicole Takahashi write in the May issue of the
American Journal of Medical Genetics.
'Time to Move On'
To test the theory, the two researchers determined the Rh status of 214
mothers who had children with an autism spectrum disorder and reviewed medical
records to determine if the Rh-negative women had received the Rh protein
vaccine late in pregnancy.
Rh-negative status was found to be no higher in the mothers of the autistic
children than in the general population, nor was there more exposure to
thimerosal-containing Rh vaccine in autistic children prior to birth.
Though she knows the findings won't change the minds of those convinced that
thimerosal exposure causes autism, Miles tells WebMD that there is still no
credible scientific proof of a link.
In 2004, an expert panel convened by the Institute of Medicine (IOM) to
review the data on vaccines and autism came to the same conclusion.
"It is time to move on and focus our research dollars and efforts on
avenues that will be more productive," Miles says.